Mark C. Wiggins, Chief Business Officer at Tracon Pharmaceuticals, Inc. (TCON), bought 1,000 shares at $10.57 ($11K) on 2020-12-29, disclosed to the SEC on 2020-12-30.
Open-market purchase of $11k TCON by Chief Business Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.56 | 3 | $32 | 0.3% |
| 2 | $10.57 | 997 | $11K | 99.7% |
| Total | $10.57 avg | 1,000 | $11K | 100% |
| Filing → |
| TCON | BUY | 2020-01-24 | $20K | — | Filing → |
| ZGNX | SELL | 2019-08-12 | $313K | — | Filing → |
| BIIB | SELL | 2008-09-29 | $37K | — | Filing → |